Pacira BioSciences, Operating Margin vs. Return On Asset

PCRX Stock  USD 16.64  0.14  0.83%   
Based on the key profitability measurements obtained from Pacira BioSciences,'s financial statements, Pacira BioSciences, is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in December. Profitability indicators assess Pacira BioSciences,'s ability to earn profits and add value for shareholders.

Pacira BioSciences, Operating Profit Margin

0.14

At this time, Pacira BioSciences,'s Sales General And Administrative To Revenue is fairly stable compared to the past year. Operating Cash Flow Sales Ratio is likely to rise to 0.24 in 2024, whereas Price To Sales Ratio is likely to drop 2.19 in 2024. At this time, Pacira BioSciences,'s Net Income Per E B T is fairly stable compared to the past year.
For Pacira BioSciences, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Pacira BioSciences, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Pacira BioSciences, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Pacira BioSciences,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Pacira BioSciences, over time as well as its relative position and ranking within its peers.
  

Pacira BioSciences,'s Revenue Breakdown by Earning Segment

Check out Your Equity Center.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacira BioSciences,. If investors know Pacira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacira BioSciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Earnings Share
(1.98)
Revenue Per Share
15.006
Quarterly Revenue Growth
0.028
Return On Assets
0.0417
The market value of Pacira BioSciences, is measured differently than its book value, which is the value of Pacira that is recorded on the company's balance sheet. Investors also form their own opinion of Pacira BioSciences,'s value that differs from its market value or its book value, called intrinsic value, which is Pacira BioSciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacira BioSciences,'s market value can be influenced by many factors that don't directly affect Pacira BioSciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacira BioSciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacira BioSciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacira BioSciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Pacira BioSciences, Return On Asset vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Pacira BioSciences,'s current stock value. Our valuation model uses many indicators to compare Pacira BioSciences, value to that of its competitors to determine the firm's financial worth.
Pacira BioSciences, is rated below average in operating margin category among its peers. It is rated below average in return on asset category among its peers reporting about  0.32  of Return On Asset per Operating Margin. The ratio of Operating Margin to Return On Asset for Pacira BioSciences, is roughly  3.12 . At this time, Pacira BioSciences,'s Operating Profit Margin is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pacira BioSciences,'s earnings, one of the primary drivers of an investment's value.

Pacira Return On Asset vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Pacira BioSciences,

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
0.13 %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Pacira BioSciences,

Return On Asset

 = 

Net Income

Total Assets

 = 
0.0417
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Pacira Return On Asset Comparison

Pacira BioSciences, is currently under evaluation in return on asset category among its peers.

Pacira BioSciences, Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Pacira BioSciences,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Pacira BioSciences, will eventually generate negative long term returns. The profitability progress is the general direction of Pacira BioSciences,'s change in net profit over the period of time. It can combine multiple indicators of Pacira BioSciences,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income247 K259.4 K
Operating Income87.7 M92.1 M
Income Before Tax61.7 M64.8 M
Total Other Income Expense Net-26 M-24.7 M
Net Income42 M44.1 M
Income Tax Expense19.7 M20.7 M
Net Income From Continuing OpsM7.3 M
Non Operating Income Net Other-2 M-1.9 M
Net Income Applicable To Common Shares18.3 M19.2 M
Interest Income10.8 M5.8 M
Net Interest Income-17.2 M-18 M
Change To Netincome66.2 M69.5 M
Net Income Per Share 0.91  0.95 
Income Quality 3.69  3.87 
Net Income Per E B T 0.68  1.17 

Pacira Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Pacira BioSciences,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Pacira BioSciences, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Pacira BioSciences,'s important profitability drivers and their relationship over time.

Use Pacira BioSciences, in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Pacira BioSciences, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will appreciate offsetting losses from the drop in the long position's value.

Pacira BioSciences, Pair Trading

Pacira BioSciences, Pair Trading Analysis

The ability to find closely correlated positions to Pacira BioSciences, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pacira BioSciences, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pacira BioSciences, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pacira BioSciences, to buy it.
The correlation of Pacira BioSciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pacira BioSciences, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pacira BioSciences, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Pacira BioSciences, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Pacira BioSciences, position

In addition to having Pacira BioSciences, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Military Industrial Thematic Idea Now

Military Industrial
Military Industrial Theme
A collection of large United States defense contractors including companies involved in production or distribution of aircraft, ships, vehicles, weaponry, and electronic systems in cooperation with the government. The Military Industrial theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Military Industrial Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.